5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.30▲ | 7.43▼ | 7.50▼ | 8.72▼ | 7.25▲ |
MA10 | 7.34▲ | 7.57▼ | 8.10▼ | 8.42▼ | 5.56▲ |
MA20 | 7.40▼ | 8.27▼ | 8.53▼ | 7.59▼ | 4.56▲ |
MA50 | 7.75▼ | 8.76▼ | 8.63▼ | 5.32▲ | 5.73▲ |
MA100 | 8.36▼ | 8.50▼ | 8.28▼ | 4.49▲ | 9.00▼ |
MA200 | 8.55▼ | 7.57▼ | 6.29▲ | 4.70▲ | 24.95▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.027▲ | -0.094▼ | -0.194▼ | -0.089▼ | 0.659▲ |
RSI | 41.530▼ | 21.554▼ | 26.178▼ | 51.995▲ | 61.944▲ |
STOCH | 39.443 | 7.555▼ | 3.163▼ | 65.113 | 77.207 |
WILL %R | -24.138▲ | -88.482▼ | -90.000▼ | -87.365▼ | -36.391 |
CCI | 17.101 | -81.595 | -105.377▼ | -63.817 | 124.830▲ |
Friday, January 15, 2021 09:12 AM
Gainers Ceragon Networks Ltd. (NASDAQ: CRNT) shares surged 54.6% to $4.8699. Ceragon Networks is expected to release its Q4 earnings results on Monday, February 8, 2021. ObsEva SA (NASDAQ: OBSV) ...
|
Monday, January 11, 2021 05:11 AM
BERKELEY HEIGHTS, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a ...
|
Monday, January 11, 2021 04:46 AM
Anticancer Activity of Fadraciclib Monotherapy in Patients with MCL1 Amplified Solid Tumors–– Appointment of Mark Kirschbaum, M.D. as Chief Medical Officer –– $7 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/01/21 | 8.86 | 9.02 | 7.15 | 7.35 | 1,040,700 |
14/01/21 | 8.87 | 9.46 | 8.72 | 9.01 | 192,800 |
13/01/21 | 8.92 | 9.02 | 8.57 | 8.86 | 174,700 |
12/01/21 | 9.41 | 9.77 | 8.74 | 8.83 | 257,300 |
11/01/21 | 9.09 | 9.55 | 8.92 | 9.53 | 472,529 |
08/01/21 | 8.11 | 8.94 | 8.11 | 8.86 | 448,700 |
07/01/21 | 8.07 | 8.40 | 8.06 | 8.11 | 110,500 |
06/01/21 | 7.75 | 8.04 | 7.62 | 7.93 | 169,800 |
05/01/21 | 7.85 | 8.19 | 7.53 | 7.74 | 199,355 |
04/01/21 | 7.89 | 8.10 | 7.6301 | 7.97 | 279,635 |
|
|
||||
|
|
||||
|
|